QualityStocksNewsBreaks Archives - Page 4 of 1470

MondayDec 08, 2025 9:55 am

QualityStocksNewsBreaks – Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Highlights Transformative 2025 Marked by Strategic Execution and Key Milestones

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising. Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) reported that 2025 was the most transformative year in its history, driven by disciplined execution, meaningful operational milestones and continued advancement of its precious-metal portfolio in British Columbia. Against a strong macro backdrop for gold and silver, Nicola focused on exploration, permitting and revenue-oriented initiatives, beginning with February drill results that expanded the Embayment Zone and confirmed near-surface mineralization supportive of a larger copper system at Craigmont. The Company subsequently received the draft and final bulk…

MondayDec 08, 2025 9:10 am

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) Enters Option Agreement to Acquire Up to 90 Percent of Great Divide Basin Uranium Project

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) announced it has entered an option agreement to acquire up to a 90 percent interest in the Great Divide Basin uranium project in Wyoming’s Fremont and Sweetwater counties. The 2,080-acre property sits within a prolific uranium-producing region and marks Canamera’s entry into U.S. uranium exploration. CEO Brad Brodeur said the project provides a strong foundation for systematic exploration. The staged earn-in includes share issuances, cash payments, and exploration spending across three option phases, ultimately leading to a joint…

FridayDec 05, 2025 10:08 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies

Soligenix (NASDAQ: SNGX), announces its inclusion in a BioMedWire editorial examining the urgent rise of chronic and rare diseases in aging populations. With more than 30 million Americans living with rare disorders that often lack FDA-approved treatments, demand for novel therapies continues to grow. Soligenix is advancing late-stage programs including HyBryte(TM) for cutaneous T-cell lymphoma, now in its final confirmatory trial, positioning the Company at the intersection of scientific innovation and evolving national health-policy priorities focused on chronic and rare conditions. To view the full press release, visit https://ibn.fm/wtnpc About Soligenix Inc. Soligenix is a late-stage biopharmaceutical company focused on…

FridayDec 05, 2025 9:10 am

QualityStocksNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs

Belite Bio (NASDAQ: BLTE) has priced an underwritten public offering of 2,272,727 American Depositary Shares at $154.00 per ADS, with a 30-day option for underwriters to purchase up to 340,909 additional ADSs. Gross proceeds are expected to total about $350 million before fees. The Company plans to use net proceeds for commercialization preparation, pipeline development, and general corporate purposes. Morgan Stanley & Co. LLC, Leerink Partners, BofA Securities and Cantor are serving as joint active book-running managers, with H.C. Wainwright & Co. as lead manager and Maxim Group LLC and Titan Partners Group as co-managers. To view the full press…

FridayDec 05, 2025 9:00 am

QualityStocksNewsBreaks – Lelantos Holdings, Inc. (OTCID: LNTO) Engages PCAOB-Approved Auditor to Support Planned OTCQB Uplist

Lelantos Holdings (OTCID: LNTO) has engaged Aloba, Awomolo & Partners, a PCAOB-approved auditing firm, to complete its financial audits as the Company prepares an application to uplist its common stock to the OTCQB Venture Market. AAP will perform independent audits under PCAOB standards to support enhanced transparency, stronger internal controls, and alignment with OTCQB reporting requirements. Founded in 1981, the firm provides audit, tax, and financial advisory services with expertise in IFRS and PCAOB-standard external audits. Lelantos views the engagement as a key step toward improving liquidity, expanding its investor base, and increasing capital markets visibility. To view the full…

ThursdayDec 04, 2025 11:45 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) identifies Biomarker Signature Predicting Sensitivity to IV Sapu003

Oncotelic Therapeutics (OTCQB: OTLC), reports that its 45% owned joint venture, Sapu Nano, has identified a High-RICTOR/Low-RPTOR molecular signature that predicts tumor sensitivity to Sapu003, the company’s intravenous Deciparticle(TM) formulation of everolimus. The biomarker framework, to be presented at the 2025 San Antonio Breast Cancer Symposium, is based on analysis of more than 9,000 tumor samples across 20 cancer types and represents the first prospective selection strategy for IV everolimus. Data show that mTORC2-dominant tumors — including HR+/HER2- breast, lung adenocarcinoma, gastric, renal, ovarian, AML and T-cell malignancies — exhibit heightened mTOR dependency and predicted sensitivity to Sapu003, which overcomes…

ThursdayDec 04, 2025 10:01 am

QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Nu.Q NETs Assay Selected for France’s National Sepsis Detection Initiative

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that its Nu.Q® NETs H3.1 assay has been chosen as the sole biomarker for “DETECSEPS,” a French government-funded evaluation of early sepsis detection under the France 2030 plan. The program, led by the IHU SEPSIS and supported by a €6.3 million (~$7.3 million) grant, aims to transform emergency care for patients with infection and risk of sepsis progression. Professor Djillali Annane, Intensive Care Department, IHU SEPSIS, Raymond Poincaré Hospital (AP-HP) and Scientific Director of DETECSEPS, noted that combining Volition’s Nu.Q® H3.1 biomarker with a clinical score (NEWS2) could improve…

ThursdayDec 04, 2025 9:40 am

QualityStocksNewsBreaks – MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in MiningNewsWire Editorial on Rising Energy Demand and Natural Hydrogen

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announces its inclusion in a MiningNewsWire editorial exploring how surging global electricity demand — driven by rapidly expanding AI and data-center power consumption — is creating urgent need for new baseload energy solutions. The article highlights natural hydrogen as a continuously generated, geologic energy source that could offer scalable, low-carbon support for AI-era power requirements. MAX Power is noted as the first publicly traded company in North America advancing a 1.3-million-acre land position permitted for…

ThursdayDec 04, 2025 9:30 am

QualityStocksNewsBreaks – New Pacific Metals Corp. (TSX: NUAG) (NYSE American: NEWP) Reports Progress at Bolivian Silver Projects

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising. New Pacific Metals (TSX: NUAG) (NYSE American: NEWP) reports continued advancement across its Carangas silver-gold project and Silver Sand silver project in Bolivia, noting strengthened community engagement, renewed government support for foreign investment, and steady progress toward permitting and development milestones. In 2025 the Company advanced the conversion of Carangas exploration licenses to administrative mining contracts, secured a favorable community vote to proceed with consultation activities, and began negotiating a long-term framework agreement. Work is also being planned for a feasibility study supported by…

ThursdayDec 04, 2025 9:05 am

QualityStocksNewsBreaks – Shelfie-Tech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Closes $1.7 Million Private Placement

This article has been disseminated on behalf of Shelfie-Tech Ltd. and may include paid advertising. Shelfie-Tech Ltd. (CSE: SHLF) (OTCQB: SHLFF) announced it has closed its non-brokered private placement, raising $1,699,185 through the issuance of 1,179,990 common shares at $1.44 per share. The Company paid $135,934 in finders fees in accordance with applicable securities laws and Canadian Securities Exchange policies. The shares are subject to a four month hold period under Canadian securities laws. Proceeds will support research and development, potential synergetic acquisitions, and working capital. To view the full press release, visit https://ibn.fm/VNKaz About ShelfieTech ShelfieTech is a technology…

Site Search

Company Search

Category: QualityStocksNewsBreaks